Drug Shortage Report for NATESTO
| Report ID | 90647 |
| Drug Identification Number | 02450550 |
| Brand name | NATESTO |
| Common or Proper name | Testosterone gel |
| Company Name | ACERUS BIOPHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TESTOSTERONE |
| Strength(s) | 4.5% |
| Dosage form(s) | GEL |
| Route of administration | NASAL |
| Packaging size | 11g |
| ATC code | G03BA |
| ATC description | ANDROGENS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-07-31 |
| Estimated end date | |
| Actual end date | 2022-09-15 |
| Shortage status | Resolved |
| Updated date | 2023-02-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7025 LANGER DR MISSISSAUGA, ONTARIO CANADA L5N 0E8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-02-27 | French | Compare |
| v5 | 2023-02-27 | English | Compare |
| v4 | 2019-11-13 | French | Compare |
| v3 | 2019-11-13 | English | Compare |
| v2 | 2019-08-02 | French | Compare |
| v1 | 2019-08-02 | English | Compare |
Showing 1 to 6 of 6